nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—skeletal joint—systemic scleroderma	0.0427	0.204	CbGeAlD
Trisalicylate-choline—PTGS1—artery—systemic scleroderma	0.0187	0.0894	CbGeAlD
Trisalicylate-choline—PTGS2—artery—systemic scleroderma	0.0179	0.0854	CbGeAlD
Trisalicylate-choline—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.0161	0.624	CbGdCrCtD
Trisalicylate-choline—PTGS1—endothelium—systemic scleroderma	0.0158	0.0755	CbGeAlD
Trisalicylate-choline—PTGS2—endothelium—systemic scleroderma	0.0151	0.0722	CbGeAlD
Trisalicylate-choline—PTGS1—blood vessel—systemic scleroderma	0.0146	0.0696	CbGeAlD
Trisalicylate-choline—PTGS2—blood vessel—systemic scleroderma	0.0139	0.0665	CbGeAlD
Trisalicylate-choline—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00974	0.376	CbGdCrCtD
Trisalicylate-choline—PTGS1—connective tissue—systemic scleroderma	0.00747	0.0357	CbGeAlD
Trisalicylate-choline—PTGS2—connective tissue—systemic scleroderma	0.00714	0.0341	CbGeAlD
Trisalicylate-choline—PTGS1—smooth muscle tissue—systemic scleroderma	0.00683	0.0326	CbGeAlD
Trisalicylate-choline—PTGS1—skin of body—systemic scleroderma	0.00675	0.0322	CbGeAlD
Trisalicylate-choline—PTGS2—smooth muscle tissue—systemic scleroderma	0.00653	0.0312	CbGeAlD
Trisalicylate-choline—PTGS2—skin of body—systemic scleroderma	0.00645	0.0308	CbGeAlD
Trisalicylate-choline—Asthma—Mometasone—systemic scleroderma	0.00625	0.00817	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Mycophenolic acid—systemic scleroderma	0.00622	0.00813	CcSEcCtD
Trisalicylate-choline—Sweating—Pentoxifylline—systemic scleroderma	0.00619	0.00809	CcSEcCtD
Trisalicylate-choline—Epistaxis—Pentoxifylline—systemic scleroderma	0.00609	0.00796	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Mycophenolate mofetil—systemic scleroderma	0.00593	0.00775	CcSEcCtD
Trisalicylate-choline—Hepatitis—Pentoxifylline—systemic scleroderma	0.00579	0.00758	CcSEcCtD
Trisalicylate-choline—Deafness—Mycophenolic acid—systemic scleroderma	0.00558	0.00729	CcSEcCtD
Trisalicylate-choline—Lightheadedness—Lisinopril—systemic scleroderma	0.00554	0.00724	CcSEcCtD
Trisalicylate-choline—PTGS1—digestive system—systemic scleroderma	0.0054	0.0258	CbGeAlD
Trisalicylate-choline—Injection site reaction—Mycophenolate mofetil—systemic scleroderma	0.00539	0.00705	CcSEcCtD
Trisalicylate-choline—Flushing—Pentoxifylline—systemic scleroderma	0.00538	0.00703	CcSEcCtD
Trisalicylate-choline—Epistaxis—Mometasone—systemic scleroderma	0.00525	0.00687	CcSEcCtD
Trisalicylate-choline—PTGS2—digestive system—systemic scleroderma	0.00516	0.0246	CbGeAlD
Trisalicylate-choline—PTGS1—tendon—systemic scleroderma	0.00514	0.0245	CbGeAlD
Trisalicylate-choline—Erythema—Pentoxifylline—systemic scleroderma	0.00504	0.00659	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Mycophenolate mofetil—systemic scleroderma	0.00496	0.00648	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Pentoxifylline—systemic scleroderma	0.00494	0.00646	CcSEcCtD
Trisalicylate-choline—PTGS2—tendon—systemic scleroderma	0.00491	0.0234	CbGeAlD
Trisalicylate-choline—Ecchymosis—Mycophenolate mofetil—systemic scleroderma	0.00491	0.00641	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Azathioprine—systemic scleroderma	0.00459	0.006	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Mycophenolic acid—systemic scleroderma	0.00456	0.00596	CcSEcCtD
Trisalicylate-choline—Asthma—Leflunomide—systemic scleroderma	0.00452	0.00591	CcSEcCtD
Trisalicylate-choline—PTGS1—lung—systemic scleroderma	0.00451	0.0215	CbGeAlD
Trisalicylate-choline—Burning sensation—Methotrexate—systemic scleroderma	0.00442	0.00578	CcSEcCtD
Trisalicylate-choline—Deafness—Mycophenolate mofetil—systemic scleroderma	0.0044	0.00576	CcSEcCtD
Trisalicylate-choline—Hepatitis—Captopril—systemic scleroderma	0.00439	0.00574	CcSEcCtD
Trisalicylate-choline—Hallucination—Captopril—systemic scleroderma	0.00437	0.00571	CcSEcCtD
Trisalicylate-choline—Asthma—Mycophenolic acid—systemic scleroderma	0.00431	0.00564	CcSEcCtD
Trisalicylate-choline—PTGS2—lung—systemic scleroderma	0.00431	0.0206	CbGeAlD
Trisalicylate-choline—Erythema multiforme—Captopril—systemic scleroderma	0.00415	0.00543	CcSEcCtD
Trisalicylate-choline—Confusional state—Pentoxifylline—systemic scleroderma	0.00415	0.00543	CcSEcCtD
Trisalicylate-choline—Stupor—Methotrexate—systemic scleroderma	0.00412	0.00538	CcSEcCtD
Trisalicylate-choline—Oedema—Pentoxifylline—systemic scleroderma	0.00412	0.00538	CcSEcCtD
Trisalicylate-choline—Flushing—Captopril—systemic scleroderma	0.00408	0.00533	CcSEcCtD
Trisalicylate-choline—Shock—Pentoxifylline—systemic scleroderma	0.00405	0.0053	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00398	0.0052	CcSEcCtD
Trisalicylate-choline—Weight increased—Mycophenolic acid—systemic scleroderma	0.00393	0.00513	CcSEcCtD
Trisalicylate-choline—Anorexia—Pentoxifylline—systemic scleroderma	0.00392	0.00513	CcSEcCtD
Trisalicylate-choline—Asthma—Lisinopril—systemic scleroderma	0.00388	0.00508	CcSEcCtD
Trisalicylate-choline—Hypotension—Pentoxifylline—systemic scleroderma	0.00385	0.00503	CcSEcCtD
Trisalicylate-choline—Epistaxis—Leflunomide—systemic scleroderma	0.0038	0.00497	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Captopril—systemic scleroderma	0.00374	0.00489	CcSEcCtD
Trisalicylate-choline—Sweating—Mycophenolic acid—systemic scleroderma	0.00369	0.00482	CcSEcCtD
Trisalicylate-choline—Somnolence—Pentoxifylline—systemic scleroderma	0.00366	0.00478	CcSEcCtD
Trisalicylate-choline—Epistaxis—Mycophenolic acid—systemic scleroderma	0.00363	0.00474	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00362	0.00474	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Azathioprine—systemic scleroderma	0.00362	0.00474	CcSEcCtD
Trisalicylate-choline—Hepatitis—Leflunomide—systemic scleroderma	0.00362	0.00473	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00358	0.00468	CcSEcCtD
Trisalicylate-choline—Weight increased—Lisinopril—systemic scleroderma	0.00354	0.00462	CcSEcCtD
Trisalicylate-choline—Constipation—Pentoxifylline—systemic scleroderma	0.00352	0.0046	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Prednisone—systemic scleroderma	0.00351	0.00459	CcSEcCtD
Trisalicylate-choline—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00345	0.00451	CcSEcCtD
Trisalicylate-choline—Hallucination—Mycophenolic acid—systemic scleroderma	0.00344	0.00449	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Leflunomide—systemic scleroderma	0.00342	0.00447	CcSEcCtD
Trisalicylate-choline—Asthma—Mycophenolate mofetil—systemic scleroderma	0.0034	0.00445	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00339	0.00444	CcSEcCtD
Trisalicylate-choline—Anorexia—Mometasone—systemic scleroderma	0.00339	0.00443	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Prednisone—systemic scleroderma	0.00336	0.00439	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Prednisone—systemic scleroderma	0.00333	0.00435	CcSEcCtD
Trisalicylate-choline—Sweating—Lisinopril—systemic scleroderma	0.00332	0.00434	CcSEcCtD
Trisalicylate-choline—Urticaria—Pentoxifylline—systemic scleroderma	0.00327	0.00428	CcSEcCtD
Trisalicylate-choline—Epistaxis—Lisinopril—systemic scleroderma	0.00327	0.00427	CcSEcCtD
Trisalicylate-choline—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00322	0.00421	CcSEcCtD
Trisalicylate-choline—Confusional state—Captopril—systemic scleroderma	0.00315	0.00411	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Mometasone—systemic scleroderma	0.00313	0.00409	CcSEcCtD
Trisalicylate-choline—Hepatitis—Lisinopril—systemic scleroderma	0.00311	0.00407	CcSEcCtD
Trisalicylate-choline—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.0031	0.00405	CcSEcCtD
Trisalicylate-choline—Hallucination—Lisinopril—systemic scleroderma	0.00309	0.00405	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Mometasone—systemic scleroderma	0.00309	0.00404	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Leflunomide—systemic scleroderma	0.00308	0.00403	CcSEcCtD
Trisalicylate-choline—Shock—Captopril—systemic scleroderma	0.00307	0.00401	CcSEcCtD
Trisalicylate-choline—Pain—Mometasone—systemic scleroderma	0.00304	0.00397	CcSEcCtD
Trisalicylate-choline—Anorexia—Captopril—systemic scleroderma	0.00297	0.00389	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.00297	0.00388	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Lisinopril—systemic scleroderma	0.00294	0.00384	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Methotrexate—systemic scleroderma	0.00293	0.00384	CcSEcCtD
Trisalicylate-choline—Hypotension—Captopril—systemic scleroderma	0.00291	0.00381	CcSEcCtD
Trisalicylate-choline—Pruritus—Pentoxifylline—systemic scleroderma	0.00291	0.00381	CcSEcCtD
Trisalicylate-choline—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00291	0.0038	CcSEcCtD
Trisalicylate-choline—Tinnitus—Lisinopril—systemic scleroderma	0.0029	0.00379	CcSEcCtD
Trisalicylate-choline—Flushing—Lisinopril—systemic scleroderma	0.00289	0.00377	CcSEcCtD
Trisalicylate-choline—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.00286	0.00374	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00282	0.00368	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Methotrexate—systemic scleroderma	0.00278	0.00363	CcSEcCtD
Trisalicylate-choline—Somnolence—Captopril—systemic scleroderma	0.00277	0.00363	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Captopril—systemic scleroderma	0.00275	0.00359	CcSEcCtD
Trisalicylate-choline—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00272	0.00356	CcSEcCtD
Trisalicylate-choline—Lethargy—Prednisone—systemic scleroderma	0.00272	0.00356	CcSEcCtD
Trisalicylate-choline—Dizziness—Pentoxifylline—systemic scleroderma	0.00272	0.00356	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Captopril—systemic scleroderma	0.00271	0.00355	CcSEcCtD
Trisalicylate-choline—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00271	0.00354	CcSEcCtD
Trisalicylate-choline—Erythema—Lisinopril—systemic scleroderma	0.00271	0.00354	CcSEcCtD
Trisalicylate-choline—Constipation—Captopril—systemic scleroderma	0.00267	0.00349	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Lisinopril—systemic scleroderma	0.00265	0.00347	CcSEcCtD
Trisalicylate-choline—Vomiting—Pentoxifylline—systemic scleroderma	0.00262	0.00342	CcSEcCtD
Trisalicylate-choline—Rash—Pentoxifylline—systemic scleroderma	0.0026	0.00339	CcSEcCtD
Trisalicylate-choline—Dermatitis—Pentoxifylline—systemic scleroderma	0.00259	0.00339	CcSEcCtD
Trisalicylate-choline—Headache—Pentoxifylline—systemic scleroderma	0.00258	0.00337	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Captopril—systemic scleroderma	0.00257	0.00336	CcSEcCtD
Trisalicylate-choline—Hypotension—Azathioprine—systemic scleroderma	0.00254	0.00333	CcSEcCtD
Trisalicylate-choline—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00254	0.00332	CcSEcCtD
Trisalicylate-choline—Pruritus—Mometasone—systemic scleroderma	0.00251	0.00329	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00249	0.00325	CcSEcCtD
Trisalicylate-choline—Confusional state—Mycophenolic acid—systemic scleroderma	0.00247	0.00323	CcSEcCtD
Trisalicylate-choline—Oedema—Mycophenolic acid—systemic scleroderma	0.00245	0.00321	CcSEcCtD
Trisalicylate-choline—Anorexia—Leflunomide—systemic scleroderma	0.00245	0.0032	CcSEcCtD
Trisalicylate-choline—Nausea—Pentoxifylline—systemic scleroderma	0.00245	0.0032	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Mometasone—systemic scleroderma	0.00243	0.00318	CcSEcCtD
Trisalicylate-choline—Shock—Mycophenolic acid—systemic scleroderma	0.00241	0.00316	CcSEcCtD
Trisalicylate-choline—Hypotension—Leflunomide—systemic scleroderma	0.0024	0.00314	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00237	0.0031	CcSEcCtD
Trisalicylate-choline—Anorexia—Mycophenolic acid—systemic scleroderma	0.00234	0.00306	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00232	0.00304	CcSEcCtD
Trisalicylate-choline—Hypotension—Mycophenolic acid—systemic scleroderma	0.00229	0.003	CcSEcCtD
Trisalicylate-choline—Lethargy—Methotrexate—systemic scleroderma	0.00228	0.00298	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Leflunomide—systemic scleroderma	0.00226	0.00296	CcSEcCtD
Trisalicylate-choline—Vomiting—Mometasone—systemic scleroderma	0.00226	0.00295	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Azathioprine—systemic scleroderma	0.00224	0.00293	CcSEcCtD
Trisalicylate-choline—Rash—Mometasone—systemic scleroderma	0.00224	0.00293	CcSEcCtD
Trisalicylate-choline—Dermatitis—Mometasone—systemic scleroderma	0.00224	0.00293	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Leflunomide—systemic scleroderma	0.00224	0.00292	CcSEcCtD
Trisalicylate-choline—Confusional state—Lisinopril—systemic scleroderma	0.00223	0.00291	CcSEcCtD
Trisalicylate-choline—Headache—Mometasone—systemic scleroderma	0.00223	0.00291	CcSEcCtD
Trisalicylate-choline—Oedema—Lisinopril—systemic scleroderma	0.00221	0.00289	CcSEcCtD
Trisalicylate-choline—Pruritus—Captopril—systemic scleroderma	0.00221	0.00289	CcSEcCtD
Trisalicylate-choline—Pain—Leflunomide—systemic scleroderma	0.0022	0.00287	CcSEcCtD
Trisalicylate-choline—Constipation—Leflunomide—systemic scleroderma	0.0022	0.00287	CcSEcCtD
Trisalicylate-choline—Somnolence—Mycophenolic acid—systemic scleroderma	0.00218	0.00285	CcSEcCtD
Trisalicylate-choline—Shock—Lisinopril—systemic scleroderma	0.00217	0.00284	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00216	0.00282	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00214	0.00279	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Captopril—systemic scleroderma	0.00213	0.00279	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00213	0.00279	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Leflunomide—systemic scleroderma	0.00212	0.00277	CcSEcCtD
Trisalicylate-choline—Nausea—Mometasone—systemic scleroderma	0.00211	0.00276	CcSEcCtD
Trisalicylate-choline—Anorexia—Lisinopril—systemic scleroderma	0.00211	0.00275	CcSEcCtD
Trisalicylate-choline—Weight increased—Prednisone—systemic scleroderma	0.0021	0.00275	CcSEcCtD
Trisalicylate-choline—Pain—Mycophenolic acid—systemic scleroderma	0.0021	0.00274	CcSEcCtD
Trisalicylate-choline—Constipation—Mycophenolic acid—systemic scleroderma	0.0021	0.00274	CcSEcCtD
Trisalicylate-choline—Hypotension—Lisinopril—systemic scleroderma	0.00206	0.0027	CcSEcCtD
Trisalicylate-choline—Dizziness—Captopril—systemic scleroderma	0.00206	0.0027	CcSEcCtD
Trisalicylate-choline—Urticaria—Leflunomide—systemic scleroderma	0.00204	0.00267	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00202	0.00264	CcSEcCtD
Trisalicylate-choline—Vomiting—Captopril—systemic scleroderma	0.00198	0.00259	CcSEcCtD
Trisalicylate-choline—Rash—Captopril—systemic scleroderma	0.00197	0.00257	CcSEcCtD
Trisalicylate-choline—Dermatitis—Captopril—systemic scleroderma	0.00197	0.00257	CcSEcCtD
Trisalicylate-choline—Somnolence—Lisinopril—systemic scleroderma	0.00196	0.00257	CcSEcCtD
Trisalicylate-choline—Headache—Captopril—systemic scleroderma	0.00195	0.00256	CcSEcCtD
Trisalicylate-choline—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00195	0.00255	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Lisinopril—systemic scleroderma	0.00194	0.00254	CcSEcCtD
Trisalicylate-choline—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00194	0.00253	CcSEcCtD
Trisalicylate-choline—Asthma—Methotrexate—systemic scleroderma	0.00193	0.00252	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Lisinopril—systemic scleroderma	0.00192	0.00251	CcSEcCtD
Trisalicylate-choline—Shock—Mycophenolate mofetil—systemic scleroderma	0.0019	0.00249	CcSEcCtD
Trisalicylate-choline—Constipation—Lisinopril—systemic scleroderma	0.00189	0.00247	CcSEcCtD
Trisalicylate-choline—Pain—Lisinopril—systemic scleroderma	0.00189	0.00247	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00187	0.00245	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Azathioprine—systemic scleroderma	0.00186	0.00244	CcSEcCtD
Trisalicylate-choline—Nausea—Captopril—systemic scleroderma	0.00185	0.00242	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00185	0.00242	CcSEcCtD
Trisalicylate-choline—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00185	0.00241	CcSEcCtD
Trisalicylate-choline—Hallucination—Prednisone—systemic scleroderma	0.00184	0.0024	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Lisinopril—systemic scleroderma	0.00182	0.00238	CcSEcCtD
Trisalicylate-choline—Pruritus—Leflunomide—systemic scleroderma	0.00182	0.00238	CcSEcCtD
Trisalicylate-choline—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00236	CcSEcCtD
Trisalicylate-choline—Dizziness—Azathioprine—systemic scleroderma	0.0018	0.00235	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Leflunomide—systemic scleroderma	0.00176	0.0023	CcSEcCtD
Trisalicylate-choline—Urticaria—Lisinopril—systemic scleroderma	0.00176	0.00229	CcSEcCtD
Trisalicylate-choline—Pruritus—Mycophenolic acid—systemic scleroderma	0.00174	0.00227	CcSEcCtD
Trisalicylate-choline—Vomiting—Azathioprine—systemic scleroderma	0.00173	0.00226	CcSEcCtD
Trisalicylate-choline—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00225	CcSEcCtD
Trisalicylate-choline—Drowsiness—Methotrexate—systemic scleroderma	0.00172	0.00225	CcSEcCtD
Trisalicylate-choline—Rash—Azathioprine—systemic scleroderma	0.00172	0.00224	CcSEcCtD
Trisalicylate-choline—Dermatitis—Azathioprine—systemic scleroderma	0.00172	0.00224	CcSEcCtD
Trisalicylate-choline—Flushing—Prednisone—systemic scleroderma	0.00171	0.00224	CcSEcCtD
Trisalicylate-choline—Headache—Azathioprine—systemic scleroderma	0.00171	0.00223	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.0017	0.00223	CcSEcCtD
Trisalicylate-choline—Dizziness—Leflunomide—systemic scleroderma	0.0017	0.00222	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00168	0.0022	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00168	0.00219	CcSEcCtD
Trisalicylate-choline—Pain—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00216	CcSEcCtD
Trisalicylate-choline—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00216	CcSEcCtD
Trisalicylate-choline—Sweating—Methotrexate—systemic scleroderma	0.00165	0.00216	CcSEcCtD
Trisalicylate-choline—Vomiting—Leflunomide—systemic scleroderma	0.00163	0.00214	CcSEcCtD
Trisalicylate-choline—Dizziness—Mycophenolic acid—systemic scleroderma	0.00162	0.00212	CcSEcCtD
Trisalicylate-choline—Epistaxis—Methotrexate—systemic scleroderma	0.00162	0.00212	CcSEcCtD
Trisalicylate-choline—Rash—Leflunomide—systemic scleroderma	0.00162	0.00212	CcSEcCtD
Trisalicylate-choline—Dermatitis—Leflunomide—systemic scleroderma	0.00162	0.00212	CcSEcCtD
Trisalicylate-choline—Nausea—Azathioprine—systemic scleroderma	0.00162	0.00211	CcSEcCtD
Trisalicylate-choline—Headache—Leflunomide—systemic scleroderma	0.00161	0.00211	CcSEcCtD
Trisalicylate-choline—Erythema—Prednisone—systemic scleroderma	0.00161	0.0021	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.0016	0.00209	CcSEcCtD
Trisalicylate-choline—Pruritus—Lisinopril—systemic scleroderma	0.00156	0.00204	CcSEcCtD
Trisalicylate-choline—Vomiting—Mycophenolic acid—systemic scleroderma	0.00156	0.00204	CcSEcCtD
Trisalicylate-choline—Rash—Mycophenolic acid—systemic scleroderma	0.00155	0.00202	CcSEcCtD
Trisalicylate-choline—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00155	0.00202	CcSEcCtD
Trisalicylate-choline—Hepatitis—Methotrexate—systemic scleroderma	0.00154	0.00202	CcSEcCtD
Trisalicylate-choline—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00201	CcSEcCtD
Trisalicylate-choline—Headache—Mycophenolic acid—systemic scleroderma	0.00154	0.00201	CcSEcCtD
Trisalicylate-choline—Nausea—Leflunomide—systemic scleroderma	0.00153	0.002	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Lisinopril—systemic scleroderma	0.00151	0.00198	CcSEcCtD
Trisalicylate-choline—Dizziness—Lisinopril—systemic scleroderma	0.00146	0.00191	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Methotrexate—systemic scleroderma	0.00146	0.00191	CcSEcCtD
Trisalicylate-choline—Nausea—Mycophenolic acid—systemic scleroderma	0.00146	0.0019	CcSEcCtD
Trisalicylate-choline—Tinnitus—Methotrexate—systemic scleroderma	0.00144	0.00188	CcSEcCtD
Trisalicylate-choline—Vomiting—Lisinopril—systemic scleroderma	0.0014	0.00184	CcSEcCtD
Trisalicylate-choline—Rash—Lisinopril—systemic scleroderma	0.00139	0.00182	CcSEcCtD
Trisalicylate-choline—Dermatitis—Lisinopril—systemic scleroderma	0.00139	0.00182	CcSEcCtD
Trisalicylate-choline—Headache—Lisinopril—systemic scleroderma	0.00138	0.00181	CcSEcCtD
Trisalicylate-choline—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00179	CcSEcCtD
Trisalicylate-choline—Erythema—Methotrexate—systemic scleroderma	0.00134	0.00176	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00173	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Methotrexate—systemic scleroderma	0.00132	0.00172	CcSEcCtD
Trisalicylate-choline—Nausea—Lisinopril—systemic scleroderma	0.00131	0.00172	CcSEcCtD
Trisalicylate-choline—Oedema—Prednisone—systemic scleroderma	0.00131	0.00172	CcSEcCtD
Trisalicylate-choline—Shock—Prednisone—systemic scleroderma	0.00129	0.00169	CcSEcCtD
Trisalicylate-choline—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00167	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Prednisone—systemic scleroderma	0.00127	0.00166	CcSEcCtD
Trisalicylate-choline—Anorexia—Prednisone—systemic scleroderma	0.00125	0.00164	CcSEcCtD
Trisalicylate-choline—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00161	CcSEcCtD
Trisalicylate-choline—Rash—Mycophenolate mofetil—systemic scleroderma	0.00122	0.0016	CcSEcCtD
Trisalicylate-choline—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00159	CcSEcCtD
Trisalicylate-choline—Headache—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00159	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Prednisone—systemic scleroderma	0.00115	0.00151	CcSEcCtD
Trisalicylate-choline—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00115	0.0015	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Prednisone—systemic scleroderma	0.00114	0.00149	CcSEcCtD
Trisalicylate-choline—Constipation—Prednisone—systemic scleroderma	0.00112	0.00147	CcSEcCtD
Trisalicylate-choline—Confusional state—Methotrexate—systemic scleroderma	0.00111	0.00145	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Prednisone—systemic scleroderma	0.00108	0.00141	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00106	0.00139	CcSEcCtD
Trisalicylate-choline—Anorexia—Methotrexate—systemic scleroderma	0.00105	0.00137	CcSEcCtD
Trisalicylate-choline—Urticaria—Prednisone—systemic scleroderma	0.00104	0.00136	CcSEcCtD
Trisalicylate-choline—Hypotension—Methotrexate—systemic scleroderma	0.00102	0.00134	CcSEcCtD
Trisalicylate-choline—Somnolence—Methotrexate—systemic scleroderma	0.000975	0.00127	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Methotrexate—systemic scleroderma	0.000965	0.00126	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Methotrexate—systemic scleroderma	0.000953	0.00125	CcSEcCtD
Trisalicylate-choline—Pain—Methotrexate—systemic scleroderma	0.000938	0.00123	CcSEcCtD
Trisalicylate-choline—Pruritus—Prednisone—systemic scleroderma	0.000928	0.00121	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Methotrexate—systemic scleroderma	0.000904	0.00118	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Prednisone—systemic scleroderma	0.000898	0.00117	CcSEcCtD
Trisalicylate-choline—Urticaria—Methotrexate—systemic scleroderma	0.000871	0.00114	CcSEcCtD
Trisalicylate-choline—Dizziness—Prednisone—systemic scleroderma	0.000868	0.00113	CcSEcCtD
Trisalicylate-choline—Vomiting—Prednisone—systemic scleroderma	0.000834	0.00109	CcSEcCtD
Trisalicylate-choline—Rash—Prednisone—systemic scleroderma	0.000827	0.00108	CcSEcCtD
Trisalicylate-choline—Dermatitis—Prednisone—systemic scleroderma	0.000827	0.00108	CcSEcCtD
Trisalicylate-choline—Headache—Prednisone—systemic scleroderma	0.000822	0.00107	CcSEcCtD
Trisalicylate-choline—Nausea—Prednisone—systemic scleroderma	0.000779	0.00102	CcSEcCtD
Trisalicylate-choline—Pruritus—Methotrexate—systemic scleroderma	0.000776	0.00101	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Methotrexate—systemic scleroderma	0.00075	0.000981	CcSEcCtD
Trisalicylate-choline—Dizziness—Methotrexate—systemic scleroderma	0.000725	0.000948	CcSEcCtD
Trisalicylate-choline—Vomiting—Methotrexate—systemic scleroderma	0.000697	0.000912	CcSEcCtD
Trisalicylate-choline—Rash—Methotrexate—systemic scleroderma	0.000691	0.000904	CcSEcCtD
Trisalicylate-choline—Dermatitis—Methotrexate—systemic scleroderma	0.000691	0.000903	CcSEcCtD
Trisalicylate-choline—Headache—Methotrexate—systemic scleroderma	0.000687	0.000898	CcSEcCtD
Trisalicylate-choline—Nausea—Methotrexate—systemic scleroderma	0.000651	0.000852	CcSEcCtD
